Publicaciones en colaboración con investigadores/as de Centro de Investigación en Red en Enfermedades Cardiovasculares (28)

2022

  1. Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial

    European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330

  2. Development of atrioventricular and intraventricular conduction disturbances in patients undergoing transcatheter aortic valve replacement with new generation self-expanding valves: A real world multicenter analysis

    International Journal of Cardiology, Vol. 362, pp. 128-136

  3. Early clinical outcomes after transaxillary versus transfemoral TAVI. Data from the Spanish TAVI registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 479-487

  4. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  5. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

  6. Selection of the best of 2021 in heart failure

    REC: CardioClinics, Vol. 57, pp. S71-S77

2021

  1. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy

    European Heart Journal, Vol. 42, Núm. 32, pp. 3063-3073

  2. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 765-772

  3. Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes

    Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791

  4. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  5. Outcomes of nonagenarians after transcatheter aortic valve implantation

    REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 250-257

  6. Rationale, design and basal characteristics of REGUEIFA study (Multicenter Registry of Atrial Fibrillation in Galicia)

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 197-207

  7. Right and left coronary chimney stenting during valve-in-valve procedure

    Revista Espanola de Cardiologia, Vol. 74, Núm. 4, pp. 345

  8. Selection of the best of 2020 in the evaluation and treatment of tricuspid regurgitation

    REC: CardioClinics, Vol. 56, pp. 72-77

  9. Self-expandable transcatheter heart valves for aortic stenosis. Short-term outcome and matched hemodynamic performance

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1033-1042

  10. TRICENTO transcatheter heart valve for severe tricuspid regurgitation. Initial experience and mid-term follow-up

    Revista Espanola de Cardiologia, Vol. 74, Núm. 4, pp. 351-354

  11. The Art of Prescribing β-Blockers After Myocardial Infarction

    Circulation: Cardiovascular Interventions, Vol. 14, Núm. 4, pp. E010720

2020

  1. Coronary perforation after intracoronary lithotripsy in a chronic total coronary occlusion

    REC: Interventional Cardiology

  2. Exercise right heart catheterization predicts outcome in asymptomatic degenerative aortic stenosis

    Revista Espanola de Cardiologia, Vol. 73, Núm. 6, pp. 457-462

  3. Predictors and outcomes of heart failure after transcatheter aortic valve implantation using a self-expanding prosthesis

    Revista Espanola de Cardiologia, Vol. 73, Núm. 5, pp. 383-392